- Home
- NCNA vs AMZE Comparison
NCNA vs AMZE Comparison
Compare NCNA & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- AMZE
- Stock Information
- Founded
- NCNA 1997
- AMZE 2019
- Country
- NCNA United Kingdom
- AMZE United States
- Employees
- NCNA N/A
- AMZE N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- NCNA Health Care
- AMZE Consumer Staples
- Exchange
- NCNA Nasdaq
- AMZE Nasdaq
- Market Cap
- NCNA 15.4M
- AMZE 16.1M
- IPO Year
- NCNA 2017
- AMZE 2021
- Fundamental
- Price
- NCNA $3.44
- AMZE $3.25
- Analyst Decision
- NCNA Buy
- AMZE
- Analyst Count
- NCNA 2
- AMZE 0
- Target Price
- NCNA $5,000.00
- AMZE N/A
- AVG Volume (30 Days)
- NCNA 733.3K
- AMZE 99.1K
- Earning Date
- NCNA 08-20-2025
- AMZE 08-14-2025
- Dividend Yield
- NCNA N/A
- AMZE N/A
- EPS Growth
- NCNA N/A
- AMZE N/A
- EPS
- NCNA N/A
- AMZE N/A
- Revenue
- NCNA N/A
- AMZE $1,054,111.00
- Revenue This Year
- NCNA N/A
- AMZE $6,741.66
- Revenue Next Year
- NCNA N/A
- AMZE $100.61
- P/E Ratio
- NCNA N/A
- AMZE N/A
- Revenue Growth
- NCNA N/A
- AMZE N/A
- 52 Week Low
- NCNA $3.05
- AMZE $2.72
- 52 Week High
- NCNA $1,856.00
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- NCNA 30.79
- AMZE 38.16
- Support Level
- NCNA $3.05
- AMZE $2.82
- Resistance Level
- NCNA $3.78
- AMZE $3.55
- Average True Range (ATR)
- NCNA 0.82
- AMZE 0.47
- MACD
- NCNA 0.11
- AMZE 0.14
- Stochastic Oscillator
- NCNA 5.61
- AMZE 32.61
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.